T11	Effect 72 114	increased risk of intracerebral hemorrhage
T13	Treatment 148 198;20 41	receiving intravenous tissue plasminogen activator preadmission warfarin
T12	Subject 118 147	patients with ischemic stroke
T15	Treat-Disorder 132 147	ischemic stroke
T9	Speculation_cue 46 86	may be associated with an increased risk
T17	Drug 33 41	warfarin
T19	Drug 159 198	ntravenous tissue plasminogen activator
T10	Adverse_event 53 63	associated
T18	Combination 148 157	receiving
E1	Adverse_event:T10 
E2	Combination:T18 arg:T17 arg2:T19
